In 1953, the discovery of DNA’s structure by Watson, Crick, and Franklin revolutionized biology and laid the foundation for modern molecular genetics. Decades later, with the Human Genome Project and digital advances, the volume of genetic and biological data grew exponentially, creating new challenges in analysis.
Bioinformatics emerged to transform these massive datasets into actionable knowledge for health and medicine. In this context, the MiRacle project was developed, combining biology with artificial intelligence to analyze genetic, protein, and molecular data with unprecedented speed and accuracy.
MiRacle’s key advantage over traditional methods is its ability to predict drug interactions precisely, reduce side effects, and accelerate drug discovery. It also identifies complex disease patterns, enabling personalized therapies.
One of MiRacle’s first achievements is the discovery of novel biological drugs for gene therapy using microRNAs, available on the official MiRacle platform.
